跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Amlopin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Amlopin
Approved
STANDARD
Amlopin
Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
55f4ce9bbff16d52
Company
Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.)
Type
Standard
Approval Details
Approval Id
55f4ce9bbff16d52
Drug Approval Philippines Name
Amlopin
Product Name
Amlopin
Registration Number
DRP-2111-04
Brand Name
Amlopin
Generic Name
Amlodipine (as Besilate)
Dosage Form
Tablet
Dosage Strength
5mg
Manufacturer
Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.)
Importer
Ambica International Corporation
Distributor
Clearvue Pharmaceutical
Issuance Date
29 March 2022
Expiry Date
16 April 2027
Pharmacologic Category
Calcium Channel Blocker
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
55f4ce9bbff16d52
Type
Standard
Back to Philippines FDA Approvals